Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Open-Label Study to Evaluate the Safety and Effectiveness of the Spirair Implant

NCT: NCT06163404 · ACTIVE_NOT_RECRUITING

NCT IDNCT06163404
StatusACTIVE_NOT_RECRUITING
Start Date2023-11-01
Completion2027-06

Brief Summary

Pilot study of bioabsorbable implant and delivery device for correction of septal deviation.

Frequently Asked Questions

What is Open-Label Study to Evaluate the Safety and Effectiveness of the Spirair Implant?

Open-Label Study to Evaluate the Safety and Effectiveness of the Spirair Implant is a clinical trial registered under NCT06163404. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06163404?

The current status of NCT06163404 (Open-Label Study to Evaluate the Safety and Effectiveness of the Spirair Implant) is: ACTIVE_NOT_RECRUITING.

When did Open-Label Study to Evaluate the Safety and Effectiveness of the Spirair Implant start?

Open-Label Study to Evaluate the Safety and Effectiveness of the Spirair Implant started on 2023-11-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑